MHRA refreshes register of licensed manufacturer's specials sites for human and veterinary medicines
The UK regulator replaced the October 2026 MS and MANSA site registers with November 2026 versions on 10 November, continuing its roughly monthly update cycle.
The Medicines and Healthcare products Regulatory Agency (MHRA) updated its register of licensed manufacturing sites on 10 November 2026. The register covers only manufacturer's specials licences for human medicines (MS) and manufacturer specials authorisations for veterinary medicines (MANSA).
According to the update log, the agency replaced the October 2026 MS and MANSA registers with the November 2026 registers. The source does not say which sites were added, amended or removed. The document titles in the page text reviewed still read October 2026, so users should check the file date they download.
The register lists all sites licensed by the Department of Health and the MHRA to manufacture human (MS) and veterinary (MANSA) medicines in the UK. The files are published as CSVs, with a separate key explaining the reference numbers used in them. For example, a 'Yes' against Reference 1.1.1.1 means a site is authorised to produce sterile aseptically prepared large volume liquids.
The page was first published on 6 February 2018 and has been refreshed most months since, with new MS and MANSA files each time. As general context, a 'specials' licence covers the manufacture of unlicensed medicines supplied to meet individual patient or animal needs.
What it means for your team
- Quality and supplier-assurance teams should download the November 2026 CSVs and check the licence status of MS and MANSA suppliers and contract manufacturers.
- Use the MS and MANSA key file to confirm that a site's listed activities match the products or dosage forms you contract it for.
- Confirm you have the November 2026 files, as the page text still shows October 2026 titles.
- The source gives no detail of individual changes, so any comparison with last month's register has to be done in-house.
Article written by VigiEye from the official source (MHRA). AI-assisted; check the source before acting.